|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/16/2024 |
$0.85 |
$0.87 |
$0.69 |
$0.73 |
1.27M | 04/17/2024 |
$0.72 |
$0.80 |
$0.71 |
$0.72 |
429.80K | 04/18/2024 |
$0.72 |
$0.75 |
$0.71 |
$0.72 |
274.20K | 04/19/2024 |
$0.70 |
$0.74 |
$0.68 |
$0.68 |
364.90K | 04/22/2024 |
$0.60 |
$0.65 |
$0.50 |
$0.51 |
3.74M |
|
Cidara Therapeutics is a biotechnology company focused on the discovery, development and commercialization of therapeutics designed for patients facing diseases. Co. is focused on infectious diseases and oncology. Co.'s primary product candidate is rezafungin acetate, an intravenous formulation of an echinocandin antifungal. Rezafungin is being developed as a once-weekly therapy for the first-line treatment and prevention of invasive fungal infections. In addition, Co. is using its Cloudbreak® platform to develop a potential new class of drugs called drug-Fc Conjugates, which target respiratory syncytial virus, human immunodeficiency virus, and the SARS-CoV-2 strains causing COVID-19. | |
|
Cidara Therapeutics (CDTX) has the following price history information. Looking back at CDTX historical stock prices for the last five trading days, on April 16, 2024, CDTX opened at $0.85, traded as high as $0.87 and as low as $0.69, and closed at $0.73. Trading volume was a total of 1.27M shares. On April 17, 2024, CDTX opened at $0.72, traded as high as $0.80 and as low as $0.71, and closed at $0.72. Trading volume was a total of 429.80K shares. On April 18, 2024, CDTX opened at $0.72, traded as high as $0.75 and as low as $0.71, and closed at $0.72. Trading volume was a total of 274.20K shares. On April 19, 2024, CDTX opened at $0.70, traded as high as $0.74 and as low as $0.68, and closed at $0.68. Trading volume was a total of 364.90K shares. On April 22, 2024, CDTX opened at $0.60, traded as high as $0.65 and as low as $0.50, and closed at $0.51. Trading volume was a total of 3.74M shares.
CDTX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cidara Therapeutics shares, starting with a $10,000 purchase of CDTX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/16/2015 |
|
End date: |
04/22/2024 |
|
Start price/share: |
$15.20 |
|
End price/share: |
$0.51 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-96.62% |
|
Average Annual Total Return: |
-31.29% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$338.19 |
|
Years: |
9.02 |
|
|
|
Date |
Close |
04/16/2024 | $0.73 | 04/17/2024 | $0.72 | 04/18/2024 | $0.72 | 04/19/2024 | $0.68 | 04/22/2024 | $0.51 |
|
|